Grey Approved Stamp

FDA Approves Medtronic’s Left Heart Lead

May 2, 2019

The FDA has given the green light for Medtronic’s Attain Stability Quad MRI SureScan, a left heart lead device designed to be used with the company’s defibrillators and pacemakers.

The device allows physicians to place the lead accurately in veins of various sizes, including ones in which positioning is difficult.

The lead enables physicians to “target the ideal location in the patient's vessel with the confidence that the lead will remain in place to allow for continued effective delivery of cardiac resynchronization therapy," said Steven Zweibel, director of electrophysiology at the Hartford Healthcare Heart and Vascular Institute.

View today's stories